Coagulation disorders encompass a spectrum of inherited and acquired conditions that disrupt the delicate balance of haemostasis, leading to either excessive bleeding or thrombosis. Among these, ...
Researchers at McMaster University have made a discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...
New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) and Factor VIII (FVIII) levels with subcutaneous dosing; ...
Blood coagulation factor XIII (FXIII) is the final transglutaminase in the clotting cascade, responsible for cross-linking fibrin polymers and stabilising the haemostatic plug. In plasma it circulates ...
Catching a scramblase in the act could pave the way to improved blood disorder and cancer treatments
Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles in all animals. The discovery could lead to new therapeutic strategies for ...
Add Yahoo as a preferred source to see more of our stories on Google. Blood clot made of red blood cells, platelets and fibrin protein strands. Thrombus, 3D illustration (Getty Images/iStockphoto) A ...
A team led by investigators from Massachusetts General Hospital used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by ...
NovoSeven RT is a prescription drug used to treat certain blood clotting disorders, including hemophilia. The drug is given as an intravenous (IV) infusion, which is an injection into a vein over a ...
To help diagnose von Willebrand disease or other bleeding disorders, a doctor will request various blood tests. These tests will measure the presence and activity of certain substances in the blood.
New, cost-effective therapy on the horizon. Magnesium improved blood clotting in case of a genetic defect of platelet development. An international team of scientists was able to demonstrate in mouse ...
A recombinant form of human ADAMTS13 approved for a different condition helped to save the life of a young mother with immune thrombotic thrombocytopenic purpura. A team led by investigators from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results